ArticleFrontiers in oncology2024

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC.

Elisa De Carlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.